A recent survey conducted by ZoomRx found that 20maximumofPharmaceutical companiesTwo-thirds of them prohibit their employees from using ChatGPT, because they are concerned about the security of sensitive internal data.
Source: The image is generated by AI, and the image is authorized by Midjourney
Despite ChatGPT’s potential to improve efficiency and effectiveness in drug development, most pharmaceutical companies are cautious about the technology. Many life science professionals use ChatGPT regularly, but 83% of them believe the technology is “overrated.”
Pharmaceutical companies generally view AI as a means to reduce costs, while also worrying about data security and privacy issues. However, there are exceptions. According to OpenAI, Moderna is conducting a pilot project called Dose ID, using ChatGPT to analyze and visualize large datasets to identifyoptimalVaccine dose.
